期刊
PREVENTIVE MEDICINE
卷 150, 期 -, 页码 -出版社
ACADEMIC PRESS INC ELSEVIER SCIENCE
DOI: 10.1016/j.ypmed.2021.106707
关键词
Quality adjusted life years; Health related quality of life; Mortality; Cigarettes; Smokeless tobacco; National Health Interview Survey
资金
- Center for Tobacco Products (CTP), U.S. Food and Drug Administration (FDA) [HHSF223201510002B]
The study aims to quantify the quality adjusted life years (QALYs) lost due to lifetime exclusive cigarette or smokeless tobacco use among U.S. adults. Results show that current exclusive cigarette or smokeless tobacco use is associated with QALY loss, with male smokers and smokeless tobacco users losing more QALYs compared to never tobacco users.
The main purpose of this analysis is to quantify quality adjusted life years (QALYs) lost associated with lifetime exclusive cigarette or smokeless tobacco use among U.S. adults. Multiple waves of National Health Interview Survey (NHIS) data linked to death certificate records were used to define current exclusive cigarette and smokeless tobacco use and associated mortality risks. NHIS data were used to assess health-related quality of life (HRQOL). Regression and Cox proportional hazard modeling were used to adjust HRQOL and mortality risk associated with tobacco use for age, sex, race/ethnicity, body mass index, education, and household poverty level. QALYs were estimated based on adjusted HRQOL and mortality risks. All analyses were initiated in 2019 and completed in 2020. Male current exclusive cigarette smokers, aged 25 to 29 years would lose 8.1 QALYs (SE = 0.09), and male current exclusive smokeless tobacco users aged 25 to 34 would lose 4.1 QALYs (SE = 0.22), compared to never users of tobacco. Current exclusive cigarette or smokeless tobacco use is associated with QALY loss. QALYs lost can be lessened through preventing the initiation of tobacco product use or helping tobacco product users quit as early in life as possible.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据